Sign In
Buy INSM
$106.92
-0.490 (-0.456%)
At Close: Jul 24, 2026
Insmed Incorporated to Post Q2 2020 Earnings of ($0.44) Per Share, SVB Leerink Forecasts (NASDAQ:INSM)
05:46am, Friday, 13'th Mar 2020
Insmed Incorporated (NASDAQ:INSM) – Analysts at SVB Leerink lifted their Q2 2020 earnings estimates for Insmed in a research report issued to clients and investors on Monday, March 9th. SVB Leerink
BidaskClub Downgrades Insmed (NASDAQ:INSM) to Sell
08:58am, Monday, 09'th Mar 2020
Insmed (NASDAQ:INSM) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, BidAsk
Insmed Incorporated (NASDAQ:INSM) Given Consensus Rating of "Buy" by Brokerages
07:38am, Sunday, 08'th Mar 2020
Insmed Incorporated (NASDAQ:INSM) has been given an average rating of “Buy” by the ten research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sel
Insmed Incorporated (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.
10:48am, Saturday, 07'th Mar 2020
Charles Schwab Investment Management Inc. increased its stake in Insmed Incorporated (NASDAQ:INSM) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund o
Asymmetry Capital Management L.P. Sells 136,709 Shares of Insmed Incorporated (NASDAQ:INSM)
02:36pm, Thursday, 05'th Mar 2020
Asymmetry Capital Management L.P. trimmed its stake in Insmed Incorporated (NASDAQ:INSM) by 54.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commissi
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01:00pm, Thursday, 05'th Mar 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
BRIEF-Insmed Announces Publication Discussing Clinical Management Of Common Respiratory Events Associated With Arikayce
01:17pm, Wednesday, 04'th Mar 2020
Insmed Inc:
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced publication of results from a surv
Edited Transcript of INSM earnings conference call or presentation 25-Feb-20 1:30pm GMT
09:56pm, Monday, 02'nd Mar 2020
Q4 2019 Insmed Inc Earnings Call
Los Angeles Capital Management & Equity Research Inc. Has $601,000 Stake in Insmed Incorporated (NASDAQ:INSM)
10:58am, Friday, 28'th Feb 2020
Los Angeles Capital Management & Equity Research Inc. grew its position in shares of Insmed Incorporated (NASDAQ:INSM) by 16.9% in the 4th quarter, according to the company in its most recent filing w
Insmed (NASDAQ:INSM) Shares Gap Down on Disappointing Earnings
07:32am, Friday, 28'th Feb 2020
Insmed Incorporated (NASDAQ:INSM) gapped down before the market opened on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $24.69, but
Insmed Incorporated Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
01:13pm, Thursday, 27'th Feb 2020
There's been a notable change in appetite for Insmed Incorporated (NASDAQ:INSM) shares in the week since its annual...
Insmed Incorporated Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
01:06pm, Thursday, 27'th Feb 2020
It's been a mediocre week for Insmed Incorporated (NASDAQ:INSM) shareholders, with the stock dropping 14% to US$26.32...
Insmed (NASDAQ:INSM) Lifted to "Buy" at ValuEngine
10:24am, Thursday, 27'th Feb 2020
Insmed (NASDAQ:INSM) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports. INSM has been the to
Galapagos Ratings Downgrade, And Other News: The Good, Bad And Ugly Of Biopharma
09:35pm, Wednesday, 26'th Feb 2020
Galapagos was down on a ratings downgrade. Insmed misses Q4 EPS. Perrigo gets an approval.
